Neither direct nor developmental exposure to bisphenol a alters the severity of experimental inflammatory colitis in mice

Journal of Immunotoxicology

Volumn 10, Issue 4, 2013, Pages 334-340

  Roy, Anirban ^a,b   Gaylo, Alison ^c   Cao, Wenqing ^d   Saubermann, Lawrence J ^b   Paige Lawrence, B ^b,c  

^a BRISTOL MYERS SQUIBB   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c Immunology/Microbiology   (United States)

^d Pathology and Laboratory Medicine   (United States)

Author keywords

Bisphenol A; Developmental immunotoxicity; Endocrine disruptor; Inflammatory bowel disease

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; COLITIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL TRACT; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, ORAL; ANIMALS; BENZHYDRYL COMPOUNDS; COLITIS; COLON; DISEASE PROGRESSION; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MATERNAL EXPOSURE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; PHENOLS; PREGNANCY; UNITED STATES; UNITED STATES ENVIRONMENTAL PROTECTION AGENCY;

EID: 84883193149     PISSN: 1547691X     EISSN: None     Source Type: Journal    
DOI: 10.3109/1547691X.2012.747231     Document Type: Article

References (43)

1. Balakrishnan, B., Henare, K., Thorstensen, E. B., et al. 2010. Transfer of bisphenol A across the human placenta. Am. J. Obstet. Gynecol. 202:393.e1-7.
2. Bauer, S., Roy, A., Emo, J., et al. 2012. The effects of maternal exposure to bisphenol A on allergic lung inflammation into adulthood. Toxicol. Sci. 130: 82-93.
3. Bebo Jr., B. F., Fyfe-Johnson, A., Adlard, K., et al. 2001. Lowdose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J. Immunol. 166:2080-2089.
4. Blumberg, R. S., Saubermann, L. J., and Strober, W. 1999. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr. Opin. Immunol. 11:648-656.
5. Bonefeld-Jorgensen, E. C., Long, M., Hofmeister, M. V., and Vinggaard, M. 2007. Endocrine disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol In Vitro: New data and a brief review. Environ. Health Perspect. 115:69-76.
6. Bouma, G., and Strober, W. 2003. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3:521-533.
7. Braniste, V., Jouault, A., Gaultier, E., et al. 2010. Impact of oral bisphenol A at reference doses on intestinal barrier function and sex differences after perinatal exposure in rats. Proc. Natl. Acad. Sci. USA. 107:448-453.
8. Calafat, A. M., Kuklenyik, Z., Reidy, J. A., et al. 2005. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ. Health Perspect. 113:391-395.
9. Domoradzki, J. Y., Pottenger, L. H., Thornton, C. M., et al. 2003. Metabolism and pharmacokinetics of bisphenol A (BPA) and the embryo-fetal distribution of BPA and BPA-monoglucuronide in CD Sprague-Dawley rats at three gestational stages. Toxicol. Sci. 76:21-34.
10. Franks, A. L., and Slansky, J. E. 2012. Multiple associations between a broad spectrum of auto-immune diseases, chronic inflammatory diseases and cancer. Anticancer Res. 32:1119-1136.
11. Gallo, D., Battaglia, A., Mantuano, E., et al. 2008. 17β-Estradiol and soy phytochemicals selectively induce a Type 2 polarization in mesenteric lymph nodes of ovariectomized rats. Menopause 15:718-725.
12. Goto, M., Takano-Ishikawa, Y., Ono, H., et al. 2007. Orally administered bisphenol A-disturbed antigen specific immunoresponses in the naïve condition. Biosci. Biotechnol. Biochem. 71:2136-2143.
13. H2 cell-promoting dendritic cells in vitro with an estrogen-like activity. Cell. Mol. Immunol. 7:227-234.
14. Hartnett, L., and Egan, L. J. 2012. Inflammation, DNA methylation and colitis-associated cancer. Carcinogenesis 33:723-831.
15. Hengstler, J. G., Foth, H., Gebel, T., et al. 2011. Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A. Crit. Rev. Toxicol. 41:263-291.
16. IRIS-EPA. 2012. Integrated Risk Information System, United States Environmental Protection Agency. Bisphenol A: CASRN 80-05-7. Available at: http://www.epa.gov/iris/subst/0356.htm [last accessed 17 October 2012].
17. Kaser, A., Zeissig, S., and Blumberg, R. S. 2010. Inflammatory bowel disease. Annu. Rev. Immunol. 28:573-621.
18. Kim, E. Y., and Moudgil, K. D. 2008. Regulation of autoimmune inflammation by pro-inflammatory cytokines. Immunol. Lett. 120:1-5.
19. Lang, I. A., Galloway, T. S., Scarlett, A., et al. 2008. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300:1303-1310.
20. +. Immunology 109:76-86.
21. Midoro-Horiuti, T., Tiwari, R., Watson, C. S., and Goldblum, R. M. 2010. Maternal bisphenol A exposure promotes the development of experimental asthma in mouse pups. Environ. Health Perspect. 118:273-277.
22. Mielke, H., and Gundert-Remy, U. 2009. Bisphenol A levels in blood depend on age and exposure. Toxicol. Lett. 190:32-40.
23. Molodecky, N. A., Panaccione, R., Ghosh, S., et al. 2011. Challenges associated with identifying the environmental determinants of the inflammatory bowel diseases. Inflam. Bowel Dis. 17:1792-1799.
24. Molodecky, N. A., Soon, I. S., Rabi, D. M., et al. 2012. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142:46-54.
25. Moriyama, K., Tagami, T., Akamizu, T., et al. 2002. Thyroid hormone action is disrupted by bisphenol A as an antagonist. J. Clin. Endocrinol. Metab. 87:5185-5190.
26. Morris, G. P., Beck, P. L., Herridge, M. S., et al. 1989. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96:795-803.
27. Nishikawa, M., Iwano, H., Yanagisawa, R., et al. 2010. Placental transfer of conjugated bisphenol A and subsequent reactivation in the rat fetus. Environ. Health Perspect. 118:1196-1203.
28. NTP (National Toxicology Program). 2008. NTP-CERHR. Monograph on the Potential Human Reproductive and Developmental Effects of Bisphenol A. NIH publication No. 08-5994. Available online at: http://ntp.niehs.nih.gov/? objectid=49C35E83-C0BC-4D5F-4AF7273D67E0 3195 [last accessed 10 September 2012].
29. Ohshima, Y., Yamada, A., Tokuriki, S., et al. 2007. Transmaternal exposure to bisphenol A modulates the development of oral tolerance. Pediatr. Res. 62:60-64.
30. Otsuka, H., Sugimoto, M., Ikeda, S., et al. 2012. Effects of bisphenol A administration to pregnant mice on serum Ca and intestinal Ca absorption. Anim. Sci. J. 83:232-237.
31. Qiu, B. S., Vallance, B. A., Blennerhassett, P. A., and Collins, S. M. 1999. The role of CD4+ lymphocytes in the susceptibility of mice to stressinduced reactivation of experimental colitis. Nat. Med. 5:1178-1182.
32. Richter, C. A., Birnbaum, L. S., Farabollini, F., et al. 2007. In vivo effects of bisphenol A in laboratory rodent studies. Repro. Toxicol. 24:199-224.
33. Roy, A., Bauer, S. M., and Lawrence, B. P. 2012. Developmental exposure to bisphenol A modulates innate but not adaptive immune responses to influenza A virus infection. PLoS ONE 7:e38448.
34. 1 mice. Environ. Health Perspect. 111:1883-1887.
35. Schonfelder, G., Wittfoht, W., Hopp, T., et al. 2002. Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ. Health Perspect. 110:A703-707.
36. Soon, I. S., Molodecky, N. A., Rabi, D. M., et al. 2012. The relationship between urban environment and the inflammatory bowel diseases: A systematic review and meta-analysis. BMC Gastroenterol. 12:51.
37. Uhlig, H. H., and Powrie, F. 2009. Autoimmune disease: inflammatory bowel disease. Eur. J. Immunol. 39:2021-2026.
38. Vandenberg, L. N., Maffini, M. V., Sonnenschein, C., et al. 2009. Bisphenol-A and the great divide: A review of controversies in the field of endocrine disruption. Endocr. Rev. 30:75-95.
39. Vom Saal, F. S., Akingbemi, B. T., Belcher, S. M., et al. 2007. Chapel Hill Bisphenol A Expert Panel Consensus Statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Repro. Toxicol. 24:131-138.
40. Westbrook, A. M., Szakmary, A., and Schiestl, R. H. 2010. Mechanisms of intestinal inflammation and development of associated cancers: Lessons learned from mouse models. Mutat. Res. 705:40-59.
41. Wetherill, Y. B., Akingbemi, B. T., Kanno, J., et al. 2007. In vitro molecular mechanisms of bisphenol A action. Repro. Toxicol. 24:178-198.
42. + regulatory T-cells. Environ. Health Perspect. 116:514-519.
43. Yoshino, S., Yamaki, K., Li, X., et al. 2004. Prenatal exposure to bisphenol A up-regulates immune responses, including T-helper 1 and T-helper 2 responses, in mice. Immunology 112:489-495.